[go: up one dir, main page]

MA32977B1 - Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol - Google Patents

Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol

Info

Publication number
MA32977B1
MA32977B1 MA34028A MA34028A MA32977B1 MA 32977 B1 MA32977 B1 MA 32977B1 MA 34028 A MA34028 A MA 34028A MA 34028 A MA34028 A MA 34028A MA 32977 B1 MA32977 B1 MA 32977B1
Authority
MA
Morocco
Prior art keywords
oxporol
polymorphic
aminomethyl
benzo
propoxy
Prior art date
Application number
MA34028A
Other languages
Arabic (ar)
English (en)
Inventor
Conrad Wheeler
Dan Todd
Pingyun Chen
Beth A Norton
Original Assignee
Anacor Pharmaceuticals Inc
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Glaxosmithkline Llc filed Critical Anacor Pharmaceuticals Inc
Publication of MA32977B1 publication Critical patent/MA32977B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRÉSENTE INVENTION CONCERNE ENTRE AUTRES DES FORMES POLYMORPHIQUES DU SEL DE CHLORHYDRATE DU (S)-3-AMINOMÉTHYL-7-(3-HYDROXY-PROPOXY)-3H-BENZO[C][1,2]OXABOROL-1-OL.
MA34028A 2008-12-17 2009-12-17 Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol MA32977B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13849008P 2008-12-17 2008-12-17
PCT/US2009/068609 WO2010080558A1 (fr) 2008-12-17 2009-12-17 Formes polymorphiques du (s)-3-aminométhyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol

Publications (1)

Publication Number Publication Date
MA32977B1 true MA32977B1 (fr) 2012-01-02

Family

ID=42316734

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34028A MA32977B1 (fr) 2008-12-17 2009-12-17 Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol

Country Status (18)

Country Link
US (1) US8461364B2 (fr)
EP (1) EP2378886A4 (fr)
JP (1) JP2012512262A (fr)
KR (1) KR20110111407A (fr)
CN (1) CN102256494A (fr)
AU (1) AU2009335744A1 (fr)
BR (1) BRPI0922566A2 (fr)
CA (1) CA2744231A1 (fr)
CO (1) CO6390029A2 (fr)
CR (1) CR20110357A (fr)
DO (1) DOP2011000183A (fr)
EA (1) EA201190034A1 (fr)
IL (1) IL213060A0 (fr)
MA (1) MA32977B1 (fr)
MX (1) MX2011006334A (fr)
PE (1) PE20120052A1 (fr)
SG (1) SG172040A1 (fr)
WO (1) WO2010080558A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009526751A (ja) 2005-12-30 2009-07-23 アナコール ファーマシューティカルズ，インコーポレイテッド ホウ素含有小分子
RU2508113C2 (ru) 2006-02-16 2014-02-27 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы в качестве противовоспалительных средств
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
SG187757A1 (en) * 2010-08-10 2013-03-28 Rempex Pharmaceuticals Inc Cyclic boronic acid ester derivatives and therapeutic uses thereof
CN108610356B (zh) 2010-09-07 2021-02-26 阿纳科制药公司 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染
CA2858799A1 (fr) 2011-12-22 2013-06-27 Micurx Pharmaceuticals, Inc. Composes de bore tricycliques pour une therapie antimicrobienne
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
NZ710723A (en) 2013-01-30 2019-12-20 Agrofresh Inc Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
WO2014121124A1 (fr) 2013-02-01 2014-08-07 Anacor Pharmaceuticals, Inc. Molécules de petite taille contenant du bore en qualité d'agents anti-protozoaires
NZ716350A (en) 2013-08-09 2022-12-23 Glaxosmithkline Ip No 2 Ltd Tricyclic benzoxaborole compounds and uses thereof
WO2016001834A1 (fr) 2014-07-01 2016-01-07 Daiichi Sankyo Company, Limited Benzoxaboroles tricycliques en tant qu'agents antibactériens
MA41494B1 (fr) 2015-02-12 2020-10-28 Glaxosmithkline Ip No 2 Ltd Composés benzoxaborole substitués en position 4 et utilisations associées
TW201735792A (zh) 2016-03-07 2017-10-16 農業保鮮股份有限公司 使用苯并氧雜硼雜環戊烯化合物和防腐氣體作為作物的抗微生物劑之協同方法
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA
KR20230121863A (ko) 2020-12-17 2023-08-21 아이덱스 래보러토리즈, 인코포레이티드 로키산 홍반열 검출 및 치료
WO2023246842A1 (fr) 2022-06-23 2023-12-28 Shanghai Micurx Pharmaceutical Co., Ltd. Promédicaments de composés de bore et leur utilisation dans le traitement d'infections bactériennes

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260336A (en) 1939-10-16 1941-10-28 Dow Chemical Co Method of preparation of organic borates
GB1396904A (en) 1972-08-11 1975-06-11 Ici Ltd Method for the control of micro-organisms
US4766113A (en) 1975-10-24 1988-08-23 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4602011A (en) 1975-10-24 1986-07-22 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US5962498A (en) 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
SG47101A1 (en) * 1992-07-31 1998-03-20 Us Bioscience Crystalline amifostine compositions and methods for the preparation and use of same
US5348948A (en) 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en) 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5594151A (en) 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
GB9604926D0 (en) 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
CA2258728C (fr) 1996-06-19 2011-09-27 Rhone Poulenc Rorer Limited Composes azabicycliques substitues et leur utilisation en tant qu'inhibiteurs de la production de tnf et de la photodiesterase cyclique d'amp
US5831046A (en) 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (fr) 1996-09-19 1998-03-26 The Board Of Trustees Of Leland Stanford Jr. University Adn methyltransferases et leur utilisation
DE19829947A1 (de) 1998-07-04 2000-01-05 Bayer Ag Elektrolumineszierende Anordnungen mit Bor-Chelaten
WO2000044387A1 (fr) 1999-01-29 2000-08-03 Nitto Kasei Co., Ltd. Composes organobores presentant une activite de coccidiostats
CA2373279A1 (fr) 1999-05-25 2000-12-14 The Penn State Research Foundation Inhibiteurs de methyltransferase d'adn
US6306628B1 (en) 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
WO2001025226A1 (fr) 1999-10-05 2001-04-12 Bethesda Pharmaceuticals, Inc. Derives de dithiolane
WO2002006316A2 (fr) 2000-07-14 2002-01-24 Zycos, Inc. Composes en rapport avec $g(a)-msh et methodes d'utilisation
EP1339725B1 (fr) 2000-11-30 2006-11-22 The Penn State Research Foundation Inhibiteurs des adn methyltransferases
DE10110051C2 (de) 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
EP1444981A1 (fr) 2001-10-11 2004-08-11 Katsuhiko Mikoshiba Inhibiteurs de l'augmentation de la concentration du calcium intracellulaire
CA2473238A1 (fr) 2002-01-10 2003-07-24 The Penn State Research Foundation Procedes de preparation d'alkyl diarylborinates et d'acides diarylboroniques complexes
US7390806B2 (en) 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
EP1581500A4 (fr) 2002-12-18 2008-03-05 Anacor Pharmaceuticals Inc Antibiotiques contenant des complexes d'acide borinique et leurs procedes d'utilisation
WO2005000200A2 (fr) 2003-05-09 2005-01-06 Sugen, Inc. Nouvelles kinases
RU2006101228A (ru) 2003-06-16 2006-07-27 Анакор Фармасьютикалз, Инк. (Us) Гидролитически устойчивые борсодержащие терапевтические агенты и способы их применения
WO2005112970A2 (fr) 2004-05-12 2005-12-01 The Brigham And Women's Hospital, Inc. Utilisation de gelsoline pour le traitement d'infections
WO2006062731A1 (fr) 2004-11-19 2006-06-15 University Of North Texas Health Science Center At Fort Worth Utilisation de la phenanthroline et de ses derives pour abaisser la tension intraoculaire d'un oeil affecte
GB0501944D0 (en) 2005-01-31 2005-03-09 Univ Cambridge Tech Compounds for use in chemical detection and/or quantitation
PT3424932T (pt) 2005-02-16 2021-05-19 Anacor Pharmaceuticals Inc Boronoftalidas para utilização terapêutica
TW200722087A (en) 2005-03-30 2007-06-16 Astion Dev As Treatment of dermatological diseases and pruritus
US20080234229A1 (en) 2005-08-18 2008-09-25 Auspex Pharmaceuticals, Inc. Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
JP2009526751A (ja) 2005-12-30 2009-07-23 アナコール ファーマシューティカルズ，インコーポレイテッド ホウ素含有小分子
RU2508113C2 (ru) 2006-02-16 2014-02-27 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы в качестве противовоспалительных средств
EP2044091A4 (fr) 2006-06-12 2010-08-04 Anacor Pharmaceuticals Inc Composés destinés au traitement d'une maladie périodontale
US20070286822A1 (en) 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
KR100895300B1 (ko) 2007-07-20 2009-05-07 한국전자통신연구원 생체신호 측정의복과 생체신호 처리시스템
WO2009111676A2 (fr) 2008-03-06 2009-09-11 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore utilisées en tant qu'agents anti-inflammatoires
WO2009140309A2 (fr) 2008-05-12 2009-11-19 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
WO2010028005A1 (fr) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
WO2010045505A1 (fr) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore en tant qu’agents antiprotozoaires

Also Published As

Publication number Publication date
WO2010080558A1 (fr) 2010-07-15
CN102256494A (zh) 2011-11-23
CO6390029A2 (es) 2012-02-29
US8461364B2 (en) 2013-06-11
US20110152217A1 (en) 2011-06-23
MX2011006334A (es) 2011-09-22
AU2009335744A1 (en) 2010-07-15
EP2378886A4 (fr) 2012-08-29
PE20120052A1 (es) 2012-02-13
EA201190034A1 (ru) 2012-02-28
JP2012512262A (ja) 2012-05-31
SG172040A1 (en) 2011-07-28
IL213060A0 (en) 2011-07-31
EP2378886A1 (fr) 2011-10-26
DOP2011000183A (es) 2011-07-15
KR20110111407A (ko) 2011-10-11
CA2744231A1 (fr) 2010-07-15
CR20110357A (es) 2011-11-11
BRPI0922566A2 (pt) 2017-03-28

Similar Documents

Publication Publication Date Title
MA32977B1 (fr) Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol
SMT201400142B (it) Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
ZA200710172B (en) Cyclic amine derivative having substituted alkyl group
EA201200741A1 (ru) Способ получения этексилата дабигатрана
CY1112467T1 (el) Παραγωγα 1-θειο-d-γλυκιτολης
MA35452B1 (fr) 3-pyrimidin-4-yl-oxazolidin-2-ones comme inhibiteurs d'idh mutante
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
BRPI0914772A2 (pt) compostos heterocíclicos 1,2-dissubstituídos
CY1112705T1 (el) Συντηγμενες κυκλικες ενωσεις
EP2481725A4 (fr) Composé amide substitué
BRPI1015540A2 (pt) ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
EA201170872A1 (ru) Ингибиторы протеинкиназы
EP2677562A3 (fr) Arylamines pour dispositifs électroluminescents organiques
EP2199282A4 (fr) Composé amide
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
SI2344465T1 (sl) Kristaliniäśne oblike (r)-5-(3-kloro-4-(2,3-dihidroksi-propoksi)- benz(z)iliden)-2-(z)-propilimino)-3-o-tolil-tiazolidin-4-ona
EA201270216A1 (ru) Фармацевтический состав
DK2010496T3 (da) 4-anilinoquinolin-3-carbonsyreamider som CSF-1R-kinaseinhibitorer
MY150778A (en) Fused heterocyclic compound
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
ITBO20060719A1 (it) Macchina per la produzione di filtri composti.
MX2011006095A (es) Dihidroetorfina y su preparacion.
SI2132204T1 (sl) Kristalinične oblike 8-azabiciklo(3.2.1) oktanske spojine
CR20140114A (es) Compuestos de benzotiazolona
EA201170721A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов рецептора хемокина